BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26608849)

  • 1. [The "treat-to-target" strategies for rheumatoid arthritis and managing for bone cartilage destructions].
    Kondo Y; Kaneko Y; Takeuchi T
    Clin Calcium; 2015 Dec; 25(12):1757-62. PubMed ID: 26608849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of bone and cartilage damage in rheumatoid arthritis].
    Komatsu N; Takayanagi H
    Clin Calcium; 2015 Dec; 25(12):1749-55. PubMed ID: 26608848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-RANKL antibody for the treatment of bone and cartilage destruction in rheumatoid arthritis].
    Nakayamada S; Tanaka Y
    Clin Calcium; 2015 Dec; 25(12):1787-93. PubMed ID: 26608853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Semaphorins as treatment targets for cartilage and bone damage caused by rheumatoid arthritis].
    Yoshida Y; Kumanogoh A
    Clin Calcium; 2015 Dec; 25(12):1795-800. PubMed ID: 26608854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The regulation of CTLA4-Ig in bone and cartilage destruction of rheumatoid arthritis].
    Iwamoto N; Kawakami A
    Clin Calcium; 2015 Dec; 25(12):1817-23. PubMed ID: 26608857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biomarker of bone and cartilage destruction in rheumatoid arthritis].
    Tanimura S; Kato M; Atsumi T
    Clin Calcium; 2015 Dec; 25(12):1769-75. PubMed ID: 26608851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treat-to-target: a tailored treatment approach to rheumatoid arthritis.
    Palmer D; El Mledany Y
    Br J Nurs; 2013 Mar 28-Apr 10; 22(6):308, 310, 312-8. PubMed ID: 23901448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Imaging assessment of bone and cartilage destruction in rheumatoid arthritis].
    Hirata S; Tanaka Y
    Clin Calcium; 2015 Dec; 25(12):1777-85. PubMed ID: 26608852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of disease modifying anti-rheumatic drugs on bone destruction in rheumatoid arthritis].
    Tsuji H; Mimori T
    Clin Calcium; 2015 Dec; 25(12):1835-42. PubMed ID: 26608859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study.
    Benham H; Rutherford M; Kirby S; Stebbings S; White D; Sim D; Harrison A
    Int J Rheum Dis; 2019 May; 22(5):874-879. PubMed ID: 30793870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paradigm shift and future perspectives in rheumatoid arthritis].
    Miyasaka N
    Nihon Rinsho; 2013 Jul; 71(7):1141-6. PubMed ID: 23961658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate: a gold standard for treatment of rheumatoid arthritis.
    Shinde CG; Venkatesh MP; Kumar TM; Shivakumar HG
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):351-8. PubMed ID: 25322199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core management principles in rheumatoid arthritis to help guide managed care professionals.
    Agarwal SK
    J Manag Care Pharm; 2011; 17(9 Suppl B):S03-8. PubMed ID: 22073933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid arthritis: 2014 treat-to-target RA recommendations--strategy is key.
    Huizinga T; Knevel R
    Nat Rev Rheumatol; 2015 Sep; 11(9):509-11. PubMed ID: 26195337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Repair of bone and articular destruction in rheumatoid arthritis].
    Kanbe K
    Clin Calcium; 2007 Apr; 17(4):541-5. PubMed ID: 17404483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.
    Bacalao EJ; Greene GJ; Beaumont JL; Eisenstein A; Muftic A; Mandelin AM; Cella D; Ruderman EM
    Clin Rheumatol; 2017 Aug; 36(8):1729-1736. PubMed ID: 28653263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical approach to a patient with rheumatoid arthritis].
    Perković D; Kaliterna DM; Krstulović DM; Bozić I; Borić K; Radić M
    Reumatizam; 2014; 61(2):24-30. PubMed ID: 25427391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis: recommendations for treat to target.
    Palmer D; El Miedany Y
    Br J Nurs; 2014 Mar 27-Apr 9; 23(6):310-5. PubMed ID: 24690926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating rheumatoid arthritis to target: a Canadian patient survey.
    Haraoui B; Bensen W; Thorne C; Wade J; Deamude M; Prince J; Légaré J
    J Clin Rheumatol; 2014 Mar; 20(2):61-7. PubMed ID: 24561407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.